Liposomal retinoid therapy in hormone refractory prostate cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 20, 2002
app pub date -
Oct 12, 2001
filing date -
Oct 16, 2000
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A method of inducing chronic remission of HRPC as well as progressive metastatic disease in a human comprising the method of administering liposomal ATRA at a dosage of at least about 100 mg/m.sup.2 at least about 2 or 3 days per week for a treatment cycle of at least about 25 to about 35 days for at least about 5 or 6 treatment cycles.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully